| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0006 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |